2011
DOI: 10.1016/j.ejphar.2010.11.022
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(22 citation statements)
references
References 25 publications
1
21
0
Order By: Relevance
“…1a, HBZY-1 cells exposed to ALA of different concentrations retained almost the same viability when compared with those cultured in normal medium, suggesting that ALA of concentration no more than 400 μM hardly affected the normal cell function. According to a previous reported study [21], LPS of 1 μg/mL was used to stimulate HBZY-1 cells. As indicated in Fig.…”
Section: Effects Of Ala On Hbzy-1 Cell Viability and The Expression Omentioning
confidence: 99%
“…1a, HBZY-1 cells exposed to ALA of different concentrations retained almost the same viability when compared with those cultured in normal medium, suggesting that ALA of concentration no more than 400 μM hardly affected the normal cell function. According to a previous reported study [21], LPS of 1 μg/mL was used to stimulate HBZY-1 cells. As indicated in Fig.…”
Section: Effects Of Ala On Hbzy-1 Cell Viability and The Expression Omentioning
confidence: 99%
“…Accumulating evidence indicates that chronic inflammation plays a critical role in several chronic degenerative pathologies, including cardiovascular diseases, renal damage, and cancer [7,8]. Several anti-LPS or anti-cytokine clinical trials have been conducted, but none has so far been successful.…”
Section: Introductionmentioning
confidence: 99%
“…It has been shown to exert beneficial effects against neurological disorders, including Alzheimer's disease, Parkinson's disease, stroke, depression, and anxiety (Watanabe et al 1983;Maruyama et al 1998;Liu et al 2005;Chen et al 2011;Xu et al 2008;Chang-Mu et al 2010). Previous studies performed in our laboratory, as well as by others, had demonstrated anti-inflammatory effects of these compounds to mitigate production of ROS, iNOS/NO, and prostaglandins/leukotrienes in BV-2 microglial cells stimulated with LPS/IFNc Kuo et al 2010;Oh et al 2009;Wu et al 2011). The mechanism of action was suggested to involve inhibition of ERK1/2 phosphorylation, NADPH oxidase activation/translocation, and NFjB activation.…”
Section: Discussionmentioning
confidence: 88%